MAPT and Alzheimer disease: However, other mechanisms, such as a direct phosphorylation of tau/APP by Chk1, and involvement of downstream targets of Chk1 other than CIP2A, may also participate in DNA damage–promoted AD pathogenesis, which needs further exploration.